slides · global inventory
Consultants Gambit
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 39,432
Current window 33,931-33,960
Pages 1,315
Rows per page 30
Arc
33,931-33,960 of 39,432
11
The slide uses a green callout box to emphasize the deal structure.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
12
AbCellera | Investor Conference Presentation Deck | 19 slidesAbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
13
The central image is a molecular model of a bispecific antibody. The layout uses a hub-and-spoke arrangement around the molecule.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
14
The slide highlights key performance indicators related to partner programs and clinical progress, accompanied by a logo grid of partners.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
15
The slide uses a three-column layout to categorize key performance indicators.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
16
The slide uses a circular arc diagram to connect the two main pillars of capital allocation to their respective sub-activities.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
17
The diagram uses a central hub-and-spoke style structure with a surrounding circular path of secondary factors.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
18
The slide uses a 'From X to Y' framing to simplify a complex scientific process.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
19
AbCellera | Investor Conference Presentation Deck | 19 slidesAbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
03
The slide uses a two-column layout to present distinct therapeutic focus areas.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Logic Chain1 hit
04
The slide uses a column-based layout with icons and supporting text to summarize company strengths.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Logic Chain1 hit
05
The slide uses a Gantt-style chart to show the status of various drug candidates (AB-729, AB-161, AB-101, AB-343) in HBV and COVID-19 programs.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Logic Chain1 hit
08
The slide uses a process-oriented flow diagram to explain the mechanism of action for a combination therapy.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Logic Chain1 hit
09
The slide highlights the mechanism of action and key clinical/preclinical benefits of the drug candidate.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Logic Chain1 hit
17
The slide uses a timeline-based process diagram to illustrate the clinical trial flow.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
18
The slide outlines two distinct study arms involving AB-729, VTP-300, and Nivolumab, with a primary focus on safety and reactogenicity.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
19
The slide details a licensing deal with Qilu Pharmaceutical, including financial terms and partner background.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
20
The slide uses a three-column layout to highlight key value propositions.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
21
Includes a line chart for efficacy over time and two bar charts for pharmacokinetic concentrations in plasma vs liver.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
22
Includes a disclaimer at the bottom regarding an FDA clinical hold.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
23
The slide uses two distinct chart types (dose-response curve and bar chart) to show efficacy in two different biological assays.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
24
Arbutus Biopharma | Investor Presentation Deck | 28 slidesArbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
25
The slide uses a biological map of the coronavirus genome to justify targeting nsp5 and nsp12.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
26
The slide highlights key therapeutic advantages of the candidate drug.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
01
HSBC | Investor Event Presentation Deck | 96 slidesHSBC | Investor Event Presentation Deck | 96 slides · HSBC
Conference presentation Investor relations Beat · Situation & Context1 hit
02
HSBC | Investor Event Presentation Deck | 96 slidesHSBC | Investor Event Presentation Deck | 96 slides · HSBC
Conference presentation Investor relations Beat · Situation & Context1 hit
03
HSBC | Investor Event Presentation Deck | 96 slidesHSBC | Investor Event Presentation Deck | 96 slides · HSBC
Conference presentation Investor relations Beat · Situation & Context1 hit
04
HSBC | Investor Event Presentation Deck | 96 slidesHSBC | Investor Event Presentation Deck | 96 slides · HSBC
Conference presentation Investor relations Beat · Situation & Context1 hit
05
HSBC | Investor Event Presentation Deck | 96 slidesHSBC | Investor Event Presentation Deck | 96 slides · HSBC
Conference presentation Investor relations Beat · Situation & Context1 hit
06
The slide uses a split-screen layout to contrast macroeconomic growth with sector-specific banking revenue growth.HSBC | Investor Event Presentation Deck | 96 slides · HSBC
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Logic Chain1 hit